Tuesday, April 15, 2025
Home Tags Fbio

Tag: fbio

2020 Watch List

There’s Simply No Loyalty Anymore.

Editor / Curator -
Roland Rick Perry, Biotech Stock Review, Frontier Bio
Biotech News

And We Have Another Double. Frontier Bio (FBIO) Crosses $4.00.

Editor / Curator -
Biotech News

Update: Biotech 5 Pack. 5 Biotech Stocks, we Expected to Double...

Editor / Curator -
biotech stock review ATXI
Biotech News

Avenue Therapeutics (ATXI) Announces New Drug Application for IV Tramadol Accepted...

Editor / Curator -
Biotech News

Fortress Bio (FBIO) Inches Closer to $3.00 on Major News.

Editor / Curator -
Immunomedics, Biotech Stock Review
All News

Biotech 5 Pack. 5 Biotech Stocks We Expect to Double in...

Editor / Curator -
All News

Citius Pharma (CTXR), Fortress Biotech (FBIO) and True Nature (TNTY) Significantly...

Editor / Curator -
Biotech News

Frontier Bio (FBIO) Bolstering it’s Warchest.

Editor / Curator -
Lindsay Rosenwald, Biotech Stock Review
Biotech News

Newsworthy: Fortress Bio (FBIO) $1.73, Gets $20 Price Target!

Editor / Curator -
Biotech News

Cougar Biotechnology. A $500,000 Investment Acquired for $1 Billion.

Editor / Curator -
12Page 1 of 2

Latest article

Adding Allarity (ALLR) $0.70, to Watch List.

2025 Watch List Editor / Curator -
LIVE QUOTE SHORT TERM CHART Bargain Hunting? Adding to the...

Bavarian Nordic (BVNRY) Freeze Dries its MPOX Vaccine!

2025 Watch List Editor / Curator -
This is Big News, Honestly. We Are Adding to 2025 Watch List @ $7.36. We last added Bavarian to...

Vaccine Biotechs Hammered After FDA Official Resigns, Citing RFK Jr.’s ‘Misinformation And Lies’ (IBD)

All News Editor / Curator -
Sorting Through the Wreckage! Full post on Investor's Business Daily. Biotech stocks took a beating Monday...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.